Two Sigma Investments, LP Verrica Pharmaceuticals Inc. Transaction History

Two Sigma Investments, LP

  • $42.8 Billion
  • Q1 2025

A detailed history of Two Sigma Investments, LP transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 88,674 shares of VRCA stock, worth $704,958. This represents 0.0% of its overall portfolio holdings.

Number of Shares
88,674
Previous 128,444 30.96%
Holding current value
$704,958
Previous $1.02 Million 31.05%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
N/A
-39,770 Reduced 30.96%
88,674 $704,000
Q4 2024

Feb 14, 2025
BUY
N/A
13,160 Added 11.42%
128,444 $1.02 Million
Q3 2024

Nov 14, 2024
BUY
$7.95 - $7.95 $576,295 - $576,295
72,490 Added 169.39%
115,284 $916,000
Q2 2024

Aug 14, 2024
BUY
$5.89 - $9.56 $104,282 - $169,259
17,705 Added 70.57%
42,794 $311,000
Q1 2024

May 15, 2024
BUY
$4.74 - $6.81 $118,921 - $170,856
25,089 New
25,089 $148,000
Q3 2023

Nov 14, 2023
SELL
$3.75 - $7.46 $18,000 - $35,808
-4,800 Reduced 6.92%
64,558 $250,000
Q2 2023

Aug 14, 2023
BUY
$5.32 - $6.79 $118,449 - $151,179
22,265 Added 47.28%
69,358 $400,000
Q1 2023

May 15, 2023
SELL
$2.88 - $8.51 $10,733 - $31,716
-3,727 Reduced 7.33%
47,093 $306,000
Q4 2022

Feb 14, 2023
BUY
$2.09 - $3.39 $4,027 - $6,532
1,927 Added 3.94%
50,820 $139,000
Q3 2022

Nov 14, 2022
SELL
$2.17 - $4.3 $11,661 - $23,108
-5,374 Reduced 9.9%
48,893 $143,000
Q2 2022

Aug 15, 2022
BUY
$1.81 - $8.93 $98,223 - $484,604
54,267 New
54,267 $104,000
Q3 2021

Nov 15, 2021
SELL
$9.55 - $13.96 $155,817 - $227,771
-16,316 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$9.77 - $15.33 $31,420 - $49,301
3,216 Added 24.55%
16,316 $184,000
Q1 2021

May 17, 2021
BUY
$10.51 - $17.46 $137,681 - $228,726
13,100 New
13,100 $198,000
Q2 2020

Aug 14, 2020
SELL
$9.02 - $15.12 $159,915 - $268,062
-17,729 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$7.14 - $16.86 $168,618 - $398,165
-23,616 Reduced 57.12%
17,729 $194,000
Q4 2019

Feb 14, 2020
BUY
$13.08 - $17.43 $540,792 - $720,643
41,345 New
41,345 $657,000
Q4 2018

Feb 14, 2019
SELL
$6.75 - $16.12 $117,207 - $279,907
-17,364 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$13.94 - $19.88 $242,054 - $345,196
17,364 New
17,364 $282,000

Others Institutions Holding VRCA

# of Institutions
72
Shares Held
20.3M
Call Options Held
0
Put Options Held
0
View Full List

About Verrica Pharmaceuticals Inc.

VRCA Quotes by TradingView
  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email